Tissue-engineered blood vessels with endothelial nitric oxide synthase activity

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 85, Issue 2, 2008, Pages 537-546

  Sang, Hyun Lim ^a   Cho, Seung Woo ^b,c   Park, Jong Chul ^d   Jeon, Oju ^b   Jae, Min Lim ^b   Kim, Sang Soo ^b   Kim, Byung Soo ^b  

^a Ajou University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Bone marrow derived cell; Endothelial nitric oxide synthase; Hybrid biodegradable polymer scaffold; Tissue engineering; Vascular graft

Indexed keywords

CALCIFICATION (BIOCHEMISTRY); ENDOTHELIAL CELLS; ENZYME ACTIVITY; GRAFTS; SCAFFOLDS; TISSUE ENGINEERING;

BONE MARROW DERIVED CELLS; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYBRID BIODEGRADABLE POLYMER SCAFFOLD; VASCULAR GRAFTS;

BLOOD VESSELS;

COLLAGEN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; POLY(LACTIDE CO EPSILON CAPROLACTONE); POLYGLACTIN; POLYLACTIDE; POLYMER;

ANIMAL CELL; ARTICLE; BLOOD VESSEL GRAFT; BONE MARROW CELL; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IMPLANTATION; MONONUCLEAR CELL; NONHUMAN; TISSUE ENGINEERING; WESTERN BLOTTING;

ANIMALS; AORTA, ABDOMINAL; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BONE MARROW CELLS; CELL DIFFERENTIATION; DOGS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MYOCYTES, SMOOTH MUSCLE; NITRIC OXIDE SYNTHASE TYPE III; POLYESTERS; POLYGLYCOLIC ACID; REGENERATION; STEM CELLS; TISSUE ENGINEERING;

EID: 42649098262     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30977     Document Type: Article

References (46)

1. Sayers RD, Raptis S, Berce M, Miller JH. Long-term results of femorotibial bypass with vein or polytetrafluoroethylene. Br J Surg 1998;85:934-938.
2. Veith FJ, Gupta SK, Ascer E, White-Flores S, Samson RH, Scher LA, Towne JB, Bernhard VM, Bonier P, Flinn WR. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3:104-114.
3. Chard RB, Johnson DC, Nunn GR, Cartmill TB. Aorta-coronary bypass grafting with polytetrafluoroethylene conduits. Early and late outcomes in eight patients. J Thorac Cardiovasc Surg 1987;94:132-134.
4. Watanabe M, Shin'oka T, Tohyama S, Hibino N, Konuma T, Matsumura G, Kosaka Y, Ishida T, Imai Y, Yamakawa M, Ikada Y, Morita S. Tissue-engineered vascular autograft: Inferior vena cava replacement in a dog model. Tissue Eng 2001;7:429-439.
5. Shinoka T, Shum-Tim D, Ma PX, Tanel RE, Isogai N, Langer R, Vacanti JP, Mayer JE Jr. Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg 1998;115:536-345.
6. Shum-Tim D, Stock U, Hrkach J, Shinoka T, Lien J, Moses MA, Stamp A, Taylor G, Moran AM, Landis W, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg 1999;68:2298-2304.
7. Matsumura G, Miyagawa-Tomita S, Shin'oka T, Ikada Y, Kurosawa H. First evidence that bone marrow cells contribute to the construction of tissue-engineered vascular autografts in vivo. Circulation 2003;108:1729-1734.
8. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med 2001;7:1035-1040.
9. Cho SW, Jeon O, Lim JE, Gwak SJ, Kim SS, Choi CY, Kim DI, Kim BS. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold. J Vasc Surg 2006;44:1329-1340.
10. Moncada S, Palmer RM, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43:109-142.
11. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100:350-356.
12. Ziche M, Morbidelli L, Masini E, Granger H, Geppetti P, Ledda F. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993;192:1198-1203.
13. Murohara T, Witzenbichler B, Spyridopoulos I, Asahara T, Ding B, Sullivan A, Losordo DW, Isner JM. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol 1999;19:1156-1161.
14. Garg UC, Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 1989;83:1774-1777.
15. Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res 1996;78:225-230.
16. Cho SW, Lim SH, Kim IK, Hong YS, Kim SS, Yoo KJ, Park HY, Jang Y, Chang BC, Choi CY, Hwang KC, Kim BS. Small-diameter blood vessels engineered with bone marrow-derived cells. Ann Surg 2005;241:506-515.
17. Cho SW, Park HJ, Ryu JH, Kim SH, Kim YH, Choi CY, Lee MJ, Kim JS, Jang IS, Kim DI, Kim BS. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices. Biomaterials 2005;26:1915-1524.
18. Cho SW, Lim JE, Chu HS, Hyun HJ, Choi CY, Hwang KC, Yoo KJ, Kim DI, Kim BS. Enhancement of in vivo endothelialization of tissue-engineered vascular grafts by granulocyte colony-stimulating factor. J Biomed Mater Res A 2006;76:252-263.
19. Kalra M, Jost CJ, Severson SR, Miller VM. Adventitial versus intimal liposome-mediated ex vivo transfection of canine saphenous vein grafts with endothelial nitric oxide synthase gene. J Vasc Surg 2000;32:1190-1200.
20. Murata M, Kador PF, Sato S. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells. J Ocul Pharmacol Ther 2000;16:383-391.
21. Ishida A, Wu MH, Shi Q, Fujita Y, Sauvage LR, Hammond WP, Wijelath ES. Dynamic changes of smooth muscle and endothelial markers in the early healing process of dacron vascular grafts in the dog, using RT-PCR. Int J Angiol 2000;9:107-110.
22. Matsumura G, Ishihara Y, Miyagawa-Tomita S, Ikada Y, Matsuda S, Kurosawa H, Shin'oka T. Evaluation of tissue-engineered vascular autografts. Tissue Eng 2006;12:3075-3083.
23. Heydarkhan-Hagvall S, Esguerra M, Helenius G, Soderberg R, Johansson BR, Risberg B. Production of extracellular matrix components in tissue-engineered blood vessels. Tissue Eng 2006;12:831-842.
24. Roh JD, Brennan MP, Lopez-Soler RI, Fong PM, Goyal A, Dardik A, Breuer CK. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: Optimization of cell harvest and seeding techniques. J Pediatr Surg 2007;42:198-202.
25. Shin'oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001;344:532-533.
26. Jeong SI, Kim BS, Lee YM, Ihn KJ, Kim SH, Kim YH. Morphology of elastic poly(L-lactide-co-ε-caprolactone) copolymers and in vitro and in vivo degradation behavior of their scaffolds. Biomacromolecules 2004;5:1303-1309.
27. Jeong SI, Kwon JH, Lim JI, Cho SW, Jung Y, Sung WJ, Kim SH, Kim YH, Lee YM, Kim BS, Choi CY, Kim SJ. Mechano-active tissue engineering of vascular smooth muscle using pulsatile perfusion bioreactors and elastic PLCL scaffolds. Biomaterials 2005;26:1405-1411.
28. Jeong SI, Kim SH, Kim YH, Jung Y, Kwon JH, Kim BS, Lee YM. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering. J Biomater Sci Polym Ed 2004;15:645-660.
29. Ozawa T, Mickle DA, Weisel RD, Koyama N, Ozawa S, Li RK. Optimal biomaterial for creation of autologous cardiac grafts. Circulation 2002;106 (Suppl 1):I176-I182.
30. Matsubayashi K, Fedak PW, Mickle DA, Weisel RD, Ozawa T, Li RK. Improved left ventricular aneurysm repair with bioengineered vascular smooth muscle grafts. Circulation 2003;108 (Suppl II):II219-II225.
31. Hoerstrup SP, Cummings Mrcs I, Lachat M, Schoen FJ, Jenni R, Leschka S, Neuenschwander S, Schmidt D, Mol A, Gunter C, Gossi M, Genoni M, Zund G. Functional growth in tissue-engineered living, vascular grafts: Follow-up at 100 weeks in a large animal model. Circulation 2006;114 (Suppl I):I159-I166.
32. Harris LD, Kim BS, Mooney DJ. Open pore biodegradable matrices formed with gas foaming. J Biomed Mater Res 1998;42:396-402.
33. Wu Y, Zhang J, Gu Y, Li J, Chen B, Guo L, Luo T, Wang Z. Expansion of canine bone marrow-derived endothelial progenitor cells and dynamic observation. Ann Vasc Surg 2006;20:387-394.
34. Kamishina H, Deng J, Oji T, Cheeseman JA, Clemmons RM. Expression of neural markers on bone marrow-derived canine mesenchymal stem cells. Am J Vet Res 2006;67:1921-1928.
35. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972.
36. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A, Fujita Y, Kothari S, Mohle R, Sauvage LR, Moore MA, Storb RF, Hammond WP. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998;92:362-367.
37. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human post-natal bone marrow. J Clin Invest 2002;109:337-346.
38. Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, Hirai H, Makuuchi M, Hirata Y, Nagai R. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002;8:403-409.
39. Shimizu K, Sugiyama S, Aikawa M, Fukumoto Y, Rabkin E, Libby P, Mitchell RN. Host bone-marrow cells are a source of donor intimal smooth-muscle-like cells in murine aortic transplant arteriopathy. Nat Med 2001;7:738-741.
40. Kashiwakura Y, Katoh Y, Tamayose K, Konishi H, Takaya N, Yuhara S, Yamada M, Sugimoto K, Daida H. Isolation of bone marrow stromal cell-derived smooth muscle cells by a human SM22α promoter: In vitro differentiation of putative smooth muscle progenitor cells of bone marrow. Circulation 2003;107:2078-2081.
41. Matsumura G, Hibino N, Ikada Y, Kurosawa H, Shin'oka T. Successful application of tissue engineered vascular autografts: Clinical experience. Biomaterials 2003;24:2303-2308.
42. Shin'oka T, Matsumura G, Hibino N, Naito Y, Watanabe M, Konuma T, Sakamoto T, Nagatsu M, Kurosawa H. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells. J Thorac Cardiovasc Surg 2005;129:1330-1338.
43. Zhang J, Qi H, Wang H, Hu P, Ou L, Guo S, Li J, Che Y, Yu Y, Kong D. Engineering of vascular grafts with genetically modified bone marrow mesenchymal stem cells on poly(propylene carbonate) graft. Artif Organs 2006;30:898-905.
44. Kader KN, Akella R, Ziats NP, Lakey LA, Harasaki H, Ranieri JP, Bellamkonda RV. eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro. Tissue Eng 2000;6:241-251.
45. Kong D, Melo LG, Mangi AA, Zhang L, Lopez-Ilasaca M, Perrella MA, Liew CC, Pratt RE, Dzau VJ. Enhanced inhibition of neointimal hyperplasia by genetically engineered endothelial progenitor cells. Circulation 2004;109:1769-1775.
46. Yu H, Dai W, Yang Z, Romaguera RL, Kirkman P, Rowe VL. Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer of nitric oxide synthase gene. J Vasc Surg 2005;41:122-129.